Schmitt CP - Search Results

1

No difference in intestinal strontium absorption after an oral or an intravenous 1,25(OH)2D3 bolus in normal subjects. For the European Study Group on Vitamin D in children with renal failure.

Bianchi ML, Ardissino GL, Schmitt CP, Daccó V, Barletta L, Claris-Appiani A, Mehls O. Bianchi ML, et al. Among authors: schmitt cp. J Bone Miner Res. 1999 Oct;14(10):1789-95. doi: 10.1359/jbmr.1999.14.10.1789. J Bone Miner Res. 1999. PMID: 10491227 Free article. Clinical Trial.

2

No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.

Ardissino G, Schmitt CP, Bianchi ML, Daccò V, Claris-Appiani A, Mehls O. Ardissino G, et al. Among authors: schmitt cp. Kidney Int. 2000 Sep;58(3):981-8. doi: 10.1046/j.1523-1755.2000.00255.x. Kidney Int. 2000. PMID: 10972662 Free article. Clinical Trial.

3

Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure.

Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O. Ardissino G, et al. Among authors: schmitt cp. Pediatr Nephrol. 2000 Jul;14(7):664-8. doi: 10.1007/s004670000365. Pediatr Nephrol. 2000. PMID: 10912539 Clinical Trial.

4

1,25(OH)2-vitamin D3 reduces spontaneous and hypocalcemia-stimulated pulsatile component of parathyroid hormone secretion.

Schmitt CP, Schaefer F, Huber D, Zahn I, Veldhuis JD, Ritz E, Mehls O. Schmitt CP, et al. J Am Soc Nephrol. 1998 Jan;9(1):54-62. doi: 10.1681/ASN.V9154. J Am Soc Nephrol. 1998. PMID: 9440087

5

Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.

Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O. Schmitt CP, et al. Kidney Int. 2000 Apr;57(4):1484-92. doi: 10.1046/j.1523-1755.2000.00993.x. Kidney Int. 2000. PMID: 10760084 Free article.

6

Daily but not pulse calcitriol therapy improves growth in experimental uremia.

Mehls O, Knöller N, Oh J, Wesch H, Wünsche B, Schmitt CP. Mehls O, et al. Among authors: schmitt cp. Pediatr Nephrol. 2000 Jul;14(7):658-63. doi: 10.1007/s004670000346. Pediatr Nephrol. 2000. PMID: 10912538

7

Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism.

Schmitt CP, Huber D, Mehls O, Maiwald J, Stein G, Veldhuis JD, Ritz E, Schaefer F. Schmitt CP, et al. J Am Soc Nephrol. 1998 Oct;9(10):1832-44. doi: 10.1681/ASN.V9101832. J Am Soc Nephrol. 1998. PMID: 9773784 Clinical Trial.

8

Differential regulation of RGS-2 by constant and oscillating PTH concentrations.

Hömme M, Schaefer F, Mehls O, Schmitt CP. Hömme M, et al. Among authors: schmitt cp. Calcif Tissue Int. 2009 Apr;84(4):305-12. doi: 10.1007/s00223-009-9222-1. Epub 2009 Feb 20. Calcif Tissue Int. 2009. PMID: 19225708

9

Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.

Hömme M, Schmitt CP, Himmele R, Hoffmann GF, Mehls O, Schaefer F. Hömme M, et al. Among authors: schmitt cp. Endocrinology. 2003 Jun;144(6):2496-504. doi: 10.1210/en.2002-0160. Endocrinology. 2003. PMID: 12746312

10

Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium.

Schmitt CP, Schaefer F, Bruch A, Veldhuis JD, Schmidt-Gayk H, Stein G, Ritz E, Mehls O. Schmitt CP, et al. J Clin Endocrinol Metab. 1996 Dec;81(12):4236-43. doi: 10.1210/jcem.81.12.8954021. J Clin Endocrinol Metab. 1996. PMID: 8954021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters